Tofacitinib Uptake by Patient-Derived Intestinal Organoids Predicts Individual Clinical Responsiveness
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Sridhar A, Bakke I, Gopalakrishnan S, Osoble N, Hammarqvist E, Pettersen H Sci Rep. 2025; 15(1):3753.
PMID: 39885201 PMC: 11782514. DOI: 10.1038/s41598-025-86314-2.
The Cell-Specific Effects of JAK1 Inhibitors in Ulcerative Colitis.
Veltkamp S, Voorneveld P J Clin Med. 2025; 14(2).
PMID: 39860613 PMC: 11766026. DOI: 10.3390/jcm14020608.
References
1.
Sandborn W, Peyrin-Biroulet L, Quirk D, Wang W, Nduaka C, Mukherjee A
. Efficacy and Safety of Extended Induction With Tofacitinib for the Treatment of Ulcerative Colitis. Clin Gastroenterol Hepatol. 2020; 20(8):1821-1830.e3.
DOI: 10.1016/j.cgh.2020.10.038.
View
2.
Flood P, Fanning A, Woznicki J, Crowley T, Christopher A, Vaccaro A
. DNA sensor-associated type I interferon signaling is increased in ulcerative colitis and induces JAK-dependent inflammatory cell death in colonic organoids. Am J Physiol Gastrointest Liver Physiol. 2022; 323(5):G439-G460.
DOI: 10.1152/ajpgi.00104.2022.
View
3.
Wittwer M, Zur A, Khuri N, Kido Y, Kosaka A, Zhang X
. Discovery of potent, selective multidrug and toxin extrusion transporter 1 (MATE1, SLC47A1) inhibitors through prescription drug profiling and computational modeling. J Med Chem. 2012; 56(3):781-795.
PMC: 4068829.
DOI: 10.1021/jm301302s.
View
4.
Woznicki J, Saini N, Flood P, Rajaram S, Lee C, Stamou P
. TNF-α synergises with IFN-γ to induce caspase-8-JAK1/2-STAT1-dependent death of intestinal epithelial cells. Cell Death Dis. 2021; 12(10):864.
PMC: 8459343.
DOI: 10.1038/s41419-021-04151-3.
View
5.
Matsuzawa-Ishimoto Y, Hine A, Shono Y, Rudensky E, Lazrak A, Yeung F
. An intestinal organoid-based platform that recreates susceptibility to T-cell-mediated tissue injury. Blood. 2020; 135(26):2388-2401.
PMC: 7317146.
DOI: 10.1182/blood.2019004116.
View